caris life sciences
PrivateLast Round
IPO
6/17/2025
Last Round Size
$494.1M
Est. Valuation
$5.9B
Total Funding Raised
$1.5B
Company Overview
Caris Life Sciences is a biotechnology company that specializes in cancer treatment through molecular science and artificial intelligence, providing profiling services that assess DNA, RNA, and proteins to enhance understanding of cancer biology and support personalized treatment decisions for patients and physicians.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
caris life sciences Comps
Related companies by embedding similarity.
caris life sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | 6/17/2025 | ||||
| Growth Equity | 4/7/2025 | ||||
| Debt | 1/19/2023 | ||||
| Growth Equity | 5/11/2021 | ||||
| Debt | 10/27/2020 | ||||
Debt | 10/1/2018 |
caris life sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about caris life sciences's valuation, stock price, and market status.
